Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$306.88 - $380.0 $8.17 Million - $10.1 Million
-26,625 Reduced 72.89%
9,903 $3.75 Million
Q3 2023

Nov 13, 2023

BUY
$315.92 - $397.36 $11.5 Million - $14.5 Million
36,528 New
36,528 $11.6 Million
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $19.9 Million - $25.4 Million
75,390 Added 2059.27%
79,051 $20.9 Million
Q2 2022

Aug 15, 2022

BUY
$301.4 - $428.42 $1.1 Million - $1.57 Million
3,661 New
3,661 $1.15 Million
Q1 2022

May 09, 2022

SELL
$379.46 - $424.54 $5.48 Million - $6.13 Million
-14,436 Closed
0 $0
Q4 2021

Feb 01, 2022

SELL
$373.53 - $434.12 $4.88 Million - $5.67 Million
-13,054 Reduced 47.49%
14,436 $6.05 Million
Q3 2021

Nov 12, 2021

BUY
$396.76 - $455.92 $10.9 Million - $12.5 Million
27,490 New
27,490 $11.4 Million
Q2 2021

Aug 13, 2021

SELL
$372.36 - $412.07 $8.41 Million - $9.31 Million
-22,589 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$357.26 - $392.57 $8.07 Million - $8.87 Million
22,589 New
22,589 $8.68 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $728,208 - $904,227
-2,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$270.93 - $320.3 $704,418 - $832,780
2,600 New
2,600 $737,000
Q4 2019

Feb 13, 2020

SELL
$281.18 - $322.05 $265,715 - $304,337
-945 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$294.25 - $341.49 $278,066 - $322,708
945 New
945 $281,000
Q2 2019

Aug 02, 2019

SELL
$279.29 - $336.89 $874,177 - $1.05 Million
-3,130 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$246.18 - $297.25 $770,543 - $930,392
3,130 New
3,130 $927,000
Q4 2018

Feb 14, 2019

SELL
$232.7 - $281.66 $182,436 - $220,821
-784 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$236.3 - $277.15 $185,259 - $217,285
784 New
784 $217,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.